✦ LIBER ✦

Being underweight may reduce your ability to mobilise peripheral blood stem cells

✍ Scribed by Mark Crowther; Alison Avenell; Dominic J. Culligan

Book ID: 116928982
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 172 KB
Volume: 43
Category: Article
ISSN: 1473-0502
DOI: 10.1016/j.transci.2010.10.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

98: Radio-Immunotherapy for Low Grade No

98: Radio-Immunotherapy for Low Grade Non-Hodgkin's Lymphoma May Impair the Ability to Mobilize Autologous Peripheral Blood Stem Cells

✍ A. Raptis; M. Mapara; A. Bilodeau; M. Hornyak; M.E. Agha 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Conditioning with high-dose cyclophospha

Conditioning with high-dose cyclophosphamide may not be sufficient to provide a long-term remission of paroxysmal nocturnal hemoglobinuria following syngeneic peripheral blood stem cell transplantation

✍ Cho, S G; Lim, J; Kim, Y; Eom, H S; Jin, C Y; Han, C W; Kim, C C 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 59 KB

The Hyper-CVAD chemotherapy regimen has

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization

✍ Colm Keane; Simon Gibbs; John F Seymour; Anthony K Mills; Karen Grimmett; Rosita 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract The Hyper‐CVAD chemotherapy regimen is being increasingly applied to a number of haematological malignancies. We assessed the impact of Hyper‐CVAD on peripheral blood stem cell (PBSC) yields and examined the optimal timing of PBSC collection when using this regimen. Seventy‐four consecu